Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 5Unknown 3Terminated 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 349Oxaliplatin 260Capecitabine 258Radiotherapy 238Gemcitabine 221Docetaxel 221Carboplatin 220Drug Therapy 216Cyclophosphamide 216apatinib 200Paclitaxel 199Bevacizumab 194camrelizumab 189Fluorouracil 187sintilimab 131Irinotecan 125Blood Specimen Collection 124Dexamethasone 122Etoposide 118toripalimab 115Surgical Procedures, Operative 115Radiosurgery 114pembrolizumab 111Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 101Surveys and Questionnaires 98tislelizumab 96Doxorubicin 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Urine Specimen Collection × Clear all
NCT05558735 2023-07-25

Contribution of Canine Detection in the Diagnostic Strategy of High-risk Prostate Cancer (Prostate-K9-Detect)

Assistance Publique - Hôpitaux de Paris

Unknown
183 enrolled
Genitourinary

Prostatic Neoplasms

NCT05705583 2023-01-31

A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

Zhejiang Cancer Hospital

Unknown
100 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡